News Results
There are 493,258 News Results
Sep 6, 2017
AKRON, Ohio, Sept. 7, 2017 /PRNewswire/ -- The Goodyear Tire & Rubber Company (NASDAQ: GT) today named new leaders in two of its strategic business units. Chris Delaney has been...
Sep 6, 2017
MADISON, N.J. and AUSTIN, Texas, Sept. 7, 2017 /PRNewswire/ -- Realogy Holdings Corp. (NYSE: RLGY) has entered into an agreement with OJO Labs, Inc. to provide its leading-edge, machine-powered assistant...
Sep 6, 2017
HONG KONG, Sept. 7, 2017 /PRNewswire/ -- The Smart City vision for Hong Kong has been further crystalised at Hong Kong Science Park, as Hong Kong Science and Technology Parks...
Sep 6, 2017
MARIETTA, Ga., Sept. 7, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected...
Sep 6, 2017
PRINCETON, N.J., Sept. 7, 2017 /PRNewswire/ -- Promius Pharma, LLC will present the previously announced (June 7, 2017) primary endpoint results of its Phase 2 study of DFN-02, a novel...
Sep 6, 2017
GRENOBLE, France, Sept. 7, 2017 /PRNewswire/ -- UPMEM , a fabless semiconductor startup company, announces UPMEM Processing In-Memory (PIM), the next generation hardware solution for data intensive applications in the...
Sep 6, 2017
SINGAPORE, Sept. 7, 2017 /PRNewswire/ -- Digital Realty (NYSE: DLR), a leading global provider of data centre, colocation and interconnection solutions, announced today it began construction on a new data...
Sep 7, 2017
INDIANAPOLIS, Sept. 8, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that treatment with self-administered galcanezumab for up to 12 months demonstrated a positive safety and tolerability...
Sep 7, 2017
SAN DIEGO, Sept. 8, 2017 /PRNewswire/ -- Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, has signed a Clinical Trial...
Sep 7, 2017
SAN DIEGO and BOSTON, Sept. 8, 2017 /PRNewswire/ -- Sevion Therapeutics, Inc. (OTCQB: SVON) and Eloxx Pharmaceuticals Ltd., a clinical stage biopharmaceutical company developing therapeutics for genetic diseases caused by...